Point72 Asset Management »

Anika Therapeutics shares owned by Point72 Asset Management

Quarter-by-quarter ownership of Anika Therapeutics (ANIK) shares owned by Point72 Asset Management from 13F filings

Historical chart of Point72 Asset Management investment in Anika Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Anika Therapeutics held by Point72 Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Anika Therapeutics by Point72 Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $558k 58k 9.61
2023-09-30 $260k 14k 18.63

More positions owned by Point72 Asset Management

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Amazon (AMZN)
Broadcom (AVGO)
Arista Networks Com Shs (ANET)
Microsoft Corporation (MSFT)
Credo Technology Group Holdi Ordinary Shares (CRDO)
Asml Holding N V N Y Registry Shs (ASML)
Spotify Technology S A SHS (SPOT)
Sea Sponsord Ads (SE)
Biogen Idec (BIIB)
Equinix (EQIX)
Coherent Corp (COHR)

View all positions for Point72 Asset Management

Top funds holding Anika Therapeutics

BlackRock
Caligan Partners
Vanguard Group
Acadian Asset Management
Boothbay Fund Management
Renaissance Technologies
Capital Management Corporation
Dimensional Fund Advisors
State Street Corporation
Geode Capital Management
Jacobs Levy Equity Management
D. E. Shaw & Co
Trigran Investments
Goldman Sachs Group
Jane Street

View all funds holding Anika Therapeutics